Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome

Molecular Immunology

Volumn 54, Issue 2, 2013, Pages 238-246

  Fan, Xinping ^a,p   Yoshida, Yoko ^b   Honda, Shigenori ^a   Matsumoto, Masanori ^b   Sawada, Yugo ^c   Hattori, Motoshi ^c   Hisanaga, Shuichi ^d   Hiwa, Ryosuke ^e   Nakamura, Fumihiko ^e   Tomomori, Maiko ^f   Miyagawa, Shinichiro ^f   Fujimaru, Rika ^g   Yamada, Hiroshi ^g   Sawai, Toshihiro ^h   Ikeda, Yuhachi ^h   Iwata, Naoyuki ⁱ   Uemura, Osamu ⁱ   Matsukuma, Eiji ^j   Aizawa, Yoshiaki ^k   Harada, Hiroshi ^l   Wada, Hideo ^m   Ishikawa, Eiji ^m   Ashida, Akira ⁿ   Nangaku, Masaomi ^o   Miyata, Toshiyuki ^a   Fujimura, Yoshihiro ^b   more..

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d Koga General Hospital   (Japan)

^e TENRI HOSPITAL   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION   (Japan)

^g OSAKA CITY GENERAL HOSPITAL   (Japan)

^h SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁱ AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

^j GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^k Iwamizawa Municipal General Hospital   (Japan)

^l SAPPORO CITY GENERAL HOSPITAL   (Japan)

^m MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁿ OSAKA MEDICAL COLLEGE   (Japan)

^o UNIVERSITY OF TOKYO   (Japan)

^p CAPITAL MEDICAL UNIVERSITY   (China)

more..

Author keywords

Alternative pathway of complement system; Atypical hemolytic uremic syndrome; Complement factor; Genetic mutation

Indexed keywords

COMPLEMENT FACTOR H; ECULIZUMAB; MEMBRANE COFACTOR PROTEIN; METHYLPREDNISOLONE; THROMBOMODULIN;

ANURIA; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEMOLYTIC UREMIC SYNDROME; HEREDITY; HETEROZYGOTE; HUMAN; JAPANESE; MALE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; JAPAN; MALE; MUTATION; PEDIGREE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; YOUNG ADULT;

EID: 84872174501     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.12.006     Document Type: Article

References (43)

1. Ariceta G., Besbas N., Johnson S., Karpman D., Landau D., Licht C., Loirat C., Pecoraro C., Taylor C.M., Van de Kar N., Vandewalle J., Zimmerhackl L.B. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatric Nephrology 2009, 24:687-696.
2. Boyce T.G., Swerdlow D.L., Griffin P.M. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. New England Journal of Medicine 1995, 333:364-368.
3. Caprioli J., Noris M., Brioschi S., Pianetti G., Castelletti F., Bettinaglio P., Mele C., Bresin E., Cassis L., Gamba S., Porrati F., Bucchioni S., Monteferrante G., Fang C.J., Liszewski M.K., Kavanagh D., Atkinson J.P., Remuzzi G. Genetics of HUS: the impact of MCPCFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006, 108:1267-1279.
4. Clemenza L., Isenman D.E. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). Journal of Immunology 2000, 165:3839-3848.
5. Delvaeye M., Noris M., De Vriese A., Esmon C.T., Esmon N.L., Ferrell G., Del-Favero J., Plaisance S., Claes B., Lambrechts D., Zoja C., Remuzzi G., Conway E.M. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. New England Journal of Medicine 2009, 361:345-357.
6. Fang C.J., Fremeaux-Bacchi V., Liszewski M.K., Pianetti G., Noris M., Goodship T.H., Atkinson J.P. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 2008, 111:624-632.
7. Francis N.J., McNicholas B., Awan A., Waldron M., Reddan D., Sadlier D., Kavanagh D., Strain L., Marchbank K.J., Harris C.L., Goodship T.H. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Blood 2012, 119:591-601.
8. Fremeaux-Bacchi V., Miller E.C., Liszewski M.K., Strain L., Blouin J., Brown A.L., Moghal N., Kaplan B.S., Weiss R.A., Lhotta K., Kapur G., Mattoo T., Nivet H., Wong W., Gie S., Hurault de Ligny B., Fischbach M., Gupta R., Hauhart R., Meunier V., Loirat C., Dragon-Durey M.A., Fridman W.H., Janssen B.J., Goodship T.H., Atkinson J.P. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008, 112:4948-4952.
9. Fremeaux-Bacchi V., Moulton E.A., Kavanagh D., Dragon-Durey M.A., Blouin J., Caudy A., Arzouk N., Cleper R., Francois M., Guest G., Pourrat J., Seligman R., Fridman W.H., Loirat C., Atkinson J.P. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology 2006, 17:2017-2025.
10. Goicoechea de Jorge E., Harris C.L., Esparza-Gordillo J., Carreras L., Arranz E.A., Garrido C.A., Lopez-Trascasa M., Sanchez-Corral P., Morgan B.P., Rodriguez de Cordoba S. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:240-245.
11. Heinen S., Sanchez-Corral P., Jackson M.S., Strain L., Goodship J.A., Kemp E.J., Skerka C., Jokiranta T.S., Meyers K., Wagner E., Robitaille P., Esparza-Gordillo J., Rodriguez de Cordoba S., Zipfel P.F., Goodship T.H. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Human Mutation 2006, 27:292-293.
12. Herbert A.P., Deakin J.A., Schmidt C.Q., Blaum B.S., Egan C., Ferreira V.P., Pangburn M.K., Lyon M., Uhrin D., Barlow P.N. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. Journal of the Biological Chemistry 2007, 282:18960-18968.
13. Heurich M., Martinez-Barricarte R., Francis N.J., Roberts D.L., Rodriguez de Cordoba S., Morgan B.P., Harris C.L. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:8761-8766.
14. Janssen B.J., Huizinga E.G., Raaijmakers H.C., Roos A., Daha M.R., Nilsson-Ekdahl K., Nilsson B., Gros P. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 2005, 437:505-511.
15. Jozsi M., Licht C., Strobel S., Zipfel S.L., Richter H., Heinen S., Zipfel P.F., Skerka C. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 2008, 111:1512-1514.
16. Kajander T., Lehtinen M.J., Hyvarinen S., Bhattacharjee A., Leung E., Isenman D.E., Meri S., Goldman A., Jokiranta T.S. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2897-2902.
17. Kato S., Matsumoto M., Matsuyama T., Isonishi A., Hiura H., Fujimura Y. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion 2006, 46:1444-1452.
18. Krawczak M., Ball E.V., Cooper D.N. Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. American Journal of Human Genetics 1998, 63:474-488.
19. Loirat C., Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet Journal of Rare Diseases 2011, 6:60.
20. Lublin D.M., Liszewski M.K., Post T.W., Arce M.A., Le Beau M.M., Rebentisch M.B., Lemons L.S., Seya T., Atkinson J.P. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. Journal of Experimental Medicine 1988, 168:181-194.
21. Maga T.K., Nishimura C.J., Weaver A.E., Frees K.L., Smith R.J. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Human Mutation 2010, 31:E1445-E1460.
22. Manuelian T., Hellwage J., Meri S., Caprioli J., Noris M., Heinen S., Jozsi M., Neumann H.P., Remuzzi G., Zipfel P.F. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. Journal of Clinical Investigation 2003, 111:1181-1190.
23. Martínez-Barricarte, R., Montes, T., Pinto, S., Sánchez-Corral, P., López-Trascasa, M., Morgan, B.P., Harris, C.L., Córdoba, S.R.d., Novel C3 mutations associated with atypical haemolytic uraemic syndrome. Poster presented at: XXII International Complement Workshop 2008. Sep. 28-Oct. 2, 2008; Basel, Switzerland.
24. Montes T., Tortajada A., Morgan B.P., Rodriguez de Cordoba S., Harris C.L. Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:4366-4371.
25. Moore I., Strain L., Pappworth I., Kavanagh D., Barlow P.N., Herbert A.P., Schmidt C.Q., Staniforth S.J., Holmes L.V., Ward R., Morgan L., Goodship T.H., Marchbank K.J. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFHCFICD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 2010, 115:379-387.
26. Morgan H.P., Schmidt C.Q., Guariento M., Blaum B.S., Gillespie D., Herbert A.P., Kavanagh D., Mertens H.D., Svergun D.I., Johansson C.M., Uhrin D., Barlow P.N., Hannan J.P. Structural basis for engagement by complement factor H of C3b on a self surface. Nature Structural and Molecular Biology 2011, 18:463-470.
27. Mukai S., Hidaka Y., Hirota-Kawadobora M., Matsuda K., Fujihara N., Takezawa Y., Kubota S., Koike K., Honda T., Yamauchi K. Factor H gene variants in Japanese: its relation to atypical hemolytic uremic syndrome. Molecular Immunology 2011, 49:48-55.
28. Noris M., Caprioli J., Bresin E., Mossali C., Pianetti G., Gamba S., Daina E., Fenili C., Castelletti F., Sorosina A., Piras R., Donadelli R., Maranta R., van der Meer I., Conway E.M., Zipfel P.F., Goodship T.H., Remuzzi G. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clinical Journal of the American Society of Nephrology 2010, 5:1844-1859.
29. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. New England Journal of Medicine 2009, 361:1676-1687.
30. Pickering M.C., de Jorge E.G., Martinez-Barricarte R., Recalde S., Garcia-Layana A., Rose K.L., Moss J., Walport M.J., Cook H.T., de Cordoba S.R., Botto M. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. Journal of Experimental Medicine 2007, 204:1249-1256.
31. Prosser B.E., Johnson S., Roversi P., Herbert A.P., Blaum B.S., Tyrrell J., Jowitt T.A., Clark S.J., Tarelli E., Uhrin D., Barlow P.N., Sim R.B., Day A.J., Lea S.M. Structural basis for complement factor H linked age-related macular degeneration. Journal of Experimental Medicine 2007, 204:2277-2283.
32. Richards A., Kemp E.J., Liszewski M.K., Goodship J.A., Lampe A.K., Decorte R., Muslumanoglu M.H., Kavukcu S., Filler G., Pirson Y., Wen L.S., Atkinson J.P., Goodship T.H. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:12966-12971.
33. Roumenina L.T., Loirat C., Dragon-Durey M.A., Halbwachs-Mecarelli L., Sautes-Fridman C., Fremeaux-Bacchi V. Alternative complement pathway assessment in patients with atypical HUS. Journal of Immunological Methods 2011, 365:8-26.
34. Saland J.M., Shneider B.L., Bromberg J.S., Shi P.A., Ward S.C., Magid M.S., Benchimol C., Seikaly M.G., Emre S.H., Bresin E., Remuzzi G. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clinical Journal of the American Society of Nephrology 2009, 4:201-206.
35. Salmon J.E., Heuser C., Triebwasser M., Liszewski M.K., Kavanagh D., Roumenina L., Branch D.W., Goodship T., Fremeaux-Bacchi V., Atkinson J.P. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Medicine 2011, 8:e1001013.
36. Sanchez-Corral P., Gonzalez-Rubio C., Rodriguez de Cordoba S., Lopez-Trascasa M. Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H. Molecular Immunology 2004, 41:81-84.
37. Sellier-Leclerc A.L., Fremeaux-Bacchi V., Dragon-Durey M.A., Macher M.A., Niaudet P., Guest G., Boudailliez B., Bouissou F., Deschenes G., Gie S., Tsimaratos M., Fischbach M., Morin D., Nivet H., Alberti C., Loirat C. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology 2007, 18:2392-2400.
38. Sethi S., Fervenza F.C. Membranoproliferative glomerulonephritis--a new look at an old entity. New England Journal of Medicine 2012, 366:1119-1131.
39. Skerka C., Jozsi M., Zipfel P.F., Dragon-Durey M.A., Fremeaux-Bacchi V. Autoantibodies in haemolytic uraemic syndrome (HUS). Journal of Thrombosis and Haemostasis 2009, 101:227-232.
40. Tarr P.I., Gordon C.A., Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365:1073-1086.
41. Tortajada A., Montes T., Martinez-Barricarte R., Morgan B.P., Harris C.L., de Cordoba S.R. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Human Molecular Genetics 2009, 18:3452-3461.
42. Venables J.P., Strain L., Routledge D., Bourn D., Powell H.M., Warwicker P., Diaz-Torres M.L., Sampson A., Mead P., Webb M., Pirson Y., Jackson M.S., Hughes A., Wood K.M., Goodship J.A., Goodship T.H. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Medicine 2006, 3:e431.
43. Zipfel P.F., Edey M., Heinen S., Jozsi M., Richter H., Misselwitz J., Hoppe B., Routledge D., Strain L., Hughes A.E., Goodship J.A., Licht C., Goodship T.H., Skerka C. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genetics 2007, 3:e41.